Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-23 Sale | 2023-05-23 5:19 pm | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 8,733 | $11.26 | $98,334 | 64,544 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-18 Exercise | 2023-05-23 5:19 pm | 2023-05-18 N/A | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 8,733 | $0 | 64,544 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-23 5:19 pm | N/A 2033-05-19 | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 24,544 | $0 | 64,544 (Direct) | View |
| 2022-05-18 Exercise(A) | 2022-07-11 06:16 am | N/A 2027-02-16 | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 10,000 | $0 | 40,000 (Direct) | View |
| 2022-05-18 Exercise(A) | 2022-07-11 06:16 am | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 10,000 | $3.62 | 40,000 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 4:08 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 23,345 | $0 | 23,345 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 9:19 pm | N/A 2031-06-14 | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 31,347 | $0 | 31,347 (Direct) | View |
Ownership | 2021-01-04 6:01 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 0 | $0 | 165,000 (Direct) | View |